Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
14 September 2021 | Story Dr Jan du Plessis and Dr Mampoi Jonas

Opinion article by Dr Jan du Plessis, Head of the Paediatric Oncology Unit, and Dr Mampoi Jonas, senior lecturer in the Paediatric Oncology, University of the Free State 


For many years childhood cancer has remained a taboo subject in our communities, mainly because too little was or is known about it. Many have known or come across an adult with cancer but for a child to be diagnosed with cancer is totally unheard of. No parent wants to hear the news that their ‘heartbeat in human form’ has fallen ill. One moment they are OK, the next, waves of emotions flood the parents. Mixed in all this are feelings of guilt, anxiety, uncertainty, constant wondering if they could have done anything differently. Most importantly the question, often unuttered remains “Is my child dying/ how much time do I have”.

Most young cancer patients live in developing countries

Childhood cancer is rare and involves only 1% of all cancers. It is reported that globally approximately 70% of all childhood cancer cases occur in low- and middle-income countries. If diagnosed early, approximately 70-80% of childhood cancers are curable in developed countries. Unfortunately, most children with cancer live in developing countries with limited resources and the cure rate does not reflect the same success. The low survival rates can be attributed to poor diagnosis coupled with too few specially trained doctors and nurses and the misbelief that child cancer is too difficult to cure. However, even in resource-poor environments at least 50% of childhood cancers can be cured.

Numerically, childhood cancer is not a significant cause of death in sub-Saharan African countries, which leaves childhood cancer less of a priority. In Africa, the most common paediatric health problems are malnutrition, infectious diseases such as HIV and tuberculosis. Whereas in Western countries, after accidents, cancer is the second leading cause of death in children and is a burden to the health system.

A study done by Stones et al in 2014 published the survival rates for children with cancer in South Africa at two different Units (Universitas and Tygerberg Hospitals) to be around 52%. The conclusion was that the children present late and with advanced-stage disease, which obviously affects their outcome. They also concluded that strategies to improve awareness of childhood cancer should be improved. Identifying early warning signs of childhood cancer is critical for parents and healthcare workers to ensure early diagnosis and improved cure rates. We often refer to these as red flag signs that should raise suspicion of the possibility of cancer as a diagnosis for the presenting patient.

Almost 85% of childhood cancers will present with the red flag signs, which could suggest the possibility of a childhood cancer, namely:
1. Pallor and purpura (bruising)
2. Bone and joint pain
3. Lymphadenopathy
4. Unexplained masses on any body part
5. Unexplained neurological signs
6. Changes in the orbit or eye
7. Persistent unexplained fever and weight loss

The most common cancer in children is leukaemia (blood cancer). Brain tumours are the most common non-haematological cancers, followed by nephroblastomas (kidney cancers) and neuroblastomas (sympathetic chain cells, the adrenal glands the most common site of origin).

We honour the children currently battling cancer and their families 

Once there is clinical suspicion of cancer, the child should be investigated or referred for the relevant investigations to be conducted to get to the right diagnosis. Treatment for childhood cancer includes chemotherapy, surgery or radiotherapy. These may be given separately or in combination depending on the diagnosis. Many models of care exist, but regardless of the outcome, children and families who receive compassionate, holistic care of symptomatology and address their non-physical needs are able to face their illness with dignity and energy.  

Childhood Cancer should not remain a taboo subject in South Africa and should be a topic of conversation more often so that people can be educated regarding the early warning signs and become more aware of its occurrence amongst children. Get the word out that a cure is possible. This month, which is known as Childhood Cancer Awareness Month, and throughout the year, we honour the children currently battling cancer, the families who love them, the clinicians and other caregivers treating them, the survivors of childhood cancer and the children who lost their lives to childhood cancer. 

Authors

Dr Jan Du Plessis for web 
Dr Jan du Plessis is the Head of the Paediatric  Oncology Unit in the Faculty of Health Sciences at
the University of the Free State (UFS).  


DrJonas for web
Dr Mampoi Jonas is a senior lecturer in the Paediatric Oncology, University of the Free State (UFS).

News Archive

UFS Dean scoops prestigious award for analysis of book of Malachi
2017-05-15

Description: Prof Fanie Snyman book Tags: Prof Fanie Snyman book

Willem Louw, Chairperson of the UFS Council;
Dr Khotso Mokhele , Chancellor of the UFS,
Eleanor van der Westhuizen, from the Directorate
of Research Development; Prof Francis Petersen,
UFS Vice-Chancellor and Rector; Prof Fanie Snyman,
Dean of the Faculty of Theology; and
Prof Corli Witthuhn, Vice-Rector: Research.
Photo: Johan Roux

The most sought-after award at the UFS, the annual Book Prize for Distinguished Scholarship, was recently won by Prof Fanie Snyman, Dean of the Faculty of Theology and Religion. His book, Malachi, which is about the last book of the Old Testament, has received acknowledgement through this award. He is the third academic to be awarded this prize. The book was published in English by Peeters Publishers in Belgium as part of the ”Historical Commentary on the Old Testament” series with a view to an international audience, and can be used by theology scholars and academics.

Labour of love over many years
Prof Snyman has a long history with the Bible book of Malachi. Since his student years, this book in the so-called ‘Minor Prophets’ of the Old Testament had a special charm for him. In fact, Prof Snyman has produced several publications on this concise book of 55 verses over the years. Furthermore, his doctoral thesis, as well as several papers delivered at congresses, also had this book as the theme. It took Prof Snyman about a decade to write the book.

What lies ahead for him in the future? “I am closing the book Malachi for the time being,” says Prof Snyman. “However, my research on the ‘Minor Prophets’ will continue. As a result of Malachi, InterVarsity Press in Cambridge contacted me for the writing of a book in another international commentary series, this time on the books Nahum, Habakkuk, and Zephaniah.” Prof Snyman will use his prize money of R75 000 towards this goal.

Book prize a surprise
“I can sincerely say that I did not expect the award at all. I did not know which other excellent research was submitted and thought that research from another discipline might do better. Therefore, I was completely surprised when my book was announced as the winner, and it left me speechless at the moment!” says a modest Prof Snyman.

He adds: “I am sincerely grateful for this award, but I must also thank the university. I would like to express my appreciation for the academic milieu, financial support, as well as overseas travel opportunities that have enabled me to complete the book and achieve this award.”
 
Book review by international expert
Prof Rainer Kessler, a world-renowned expert on the Bible book of Malachi, said in a review of Malachi: “The commentary on Malachi in the renowned Historical Commentary on the Old Testament series is the fruit of decades of studies on the book. [It] is full of respect towards the text. [Prof] Snyman is very cautious in his judgements and decisions. He rather presents different possibilities than uttering one-sided positions. [Finally, he] treats others always in a very fair manner. He presents their opinions as objectively as possible, especially when he does not agree. This commentary is a new and very useful tool for the study on the often underestimated last book of the Old Testament prophets.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept